Foreign body obstructing fresh gas flow through disposable breathing circuit
Sir,
The presence of an unrecognised 'foreign body' in the anaesthetic equipment has the potential to cost a human life. The Association of Anaesthetists of Great Britain and Ireland [AAGBI] have given guidelines for conducting pre-use machine check. [1] We present a case of 56-year-old female patient with carcinoma breast posted for modified radical mastectomy. History, physical examination and blood investigations were unremarkable except for hepatitis-B-surface-antigen positive serology. On the day of the procedure we followed automated check-out on Drager-Fabius machine. A disposable circuit (K&L-Kyoling R ) was used. Two-bag test was done. Standard anaesthesia monitors were connected on patient and midazolam intravenous [IV] 1 mg was given. During preoxygenation, the patient became very anxious and was feeling claustrophobic with a well-fitting face-mask and good-seal. She was reassured and oxygen insufflated through face-mask and general anaesthesia was induced with propofol IV-100mg and fentanyl IV-80µg. We noticed that we were not able to mask ventilate the lungs. Anticipating tongue fall, we used an oral-airway and improved the mask-seal, but could not ventilate the lungs. There was no visible chest rise. Rising airway pressure on monitors and increased compliance of the bag were appreciated. The bag began to distend despite the adjustable-pressure-limiting Letters to Editor we disconnected the circuit to use artificialmanual-breathing-unit [AMBU] for ventilation. On disconnecting the circuit we noticed a cap jammed into the mask which was acting like a foreign-body preventing fresh-gas-flow [ Figure 1 ]. We were able to ventilate the patient using breathing circuit after removing the foreign-body. The rest of case went uneventfully.
On analysis, it was found out that the cap which was jammed in face-mask was part of disposable breathing circuit. This cap was inadvertently not removed before connecting to the mask. On disconnecting the mask to perform Two-bag test prior to use, the cap was retained in the anatomic face-mask. After clearing the leak test, the circuit was reconnected to the mask having the retained cap.
The diagnosis of a blocked breathing circuit as the cause for failure to ventilate the patient is of paramount importance in ameliorating a life threatening situation as this may mimic other clinical conditions of silent chest [2] where our attention will be diverted leaving the machine component unattended. Both device related and human factors can contribute to the mishap during induction. Better understanding of anaesthesia machine and checking its each component for proper functioning prior to use may minimise the catastrophic events. [3] This incident could have been avoided by visual inspection during assembly of the breathing circuit, circuit cap of different colour from that of circuit would have been easily identifiable and by use of a translucent mask instead of the opaque anatomical face mask that obscured the view of the cap inside. Old school practice of feeling for fresh gas flow by operator before use also could have hinted at obstruction to flow. Preoxygenation with well-fitting face-mask would have hinted at obstruction much earlier due to absence of bag movement.
Availability of AMBU cannot be over emphasised. AMBU is failsafe in case of equipment malfunction leading to failed gas delivery to patient. We could save precious time by ventilating patient with AMBU when we are not able to ventilate using anaesthesia machine.
Mechanical obstruction in the ventilator circuit due to heat-moisture-exchange filter, IV-cannula cap, faulty equipment or unusual bodies like plastic wrapping have been reported leading to unfortunate events. [4] This article highlights that anaesthesiologists and technicians should inspect breathing circuit for correct configuration, assembly and proper functioning. Breathing systems should be protected at patient end when not in use to prevent intrusion of foreign-body. The cap may have been provided by manufacturer of the disposable-circuit to prevent any foreign body intrusion while not in use. [3, 5] Declaration of patient consent The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/ her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
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Labour epidural analgesia in Hypertrophic Obstructive Cardiomyopathy
Sir, Labour epidural analgesia has been shown to be safe and beneficial in parturients with complex cardiac conditions, and reduces maternal and foetal morbidity and mortality. Reported incidence of hypertrophic obstructive cardiomyopathy (HOCM) in pregnancy is approximately 2 per 1000. [1] Pregnancy associated with HOCM is a rare occurrence; it poses a significant morbidity and mortality risk to both mother and foetus. [2] Here we discuss two cases of pregnancy with HOCM managed successfully using epidural labour analgesia.
A 26-year-old primigravida at 35 weeks of gestation presented with history of palpitations since 28 weeks of gestation. There was no history of breathlessness, syncope, abdominal distention and leg swelling. Further workup and echocardiography revealed asymmetrical septal hypertrophy with thickness 3.25 cm. Systolic anterior motion (SAM) of mitral leaflet was present. Left ventricular outflow tract peak pressure gradient was 120 mm Hg and mean gradient was 30 mm Hg. She was diagnosed as a case of HOCM and started on tablet metoprolol extended release 25 mg BD. On examination, her pulse rate was 100/min and BP was 100/60 mm Hg. She was started on oxytocin infusion for induction of labour and planned for labour analgesia. Epidural labour analgesia was provided with a bolus of 10 ml of 0.0625% Bupivacaine with 2 mcg per ml fentanyl administered in divided doses to achieve a level sensory level of T9 to L1. Maintenance dose of bupivacaine and fentanyl of same concentration at 8 ml/hour was continued. Continuous maternal and foetal monitoring was done.
The second patient was a 32-year-old G 3 P 2 L 0 presented at 39 weeks gestation with labour pain. She was a known case of HOCM for a period of 7 years. She had 3 rd degree atrioventricular block for which she was treated with pacemaker (DDDR mode). She was started on tablet Atenolol as a measure to reduce left ventricular outflow tract (LVOT) obstruction by achieving optimal inotropy through reducing the force of contraction, along with tablet Aspirin and Hydrochlorothiazide. With this treatment, she was NYHA class 1 during her current pregnancy and at the time of labour. Her echocardiographic findings showed septal thickness of 1.6 cm, posterior wall thickness of 8 cm with LVEF of 48%. On examination, she had bilateral pitting paedal oedema. Her HR was 86/min; BP was 110/70 mm Hg in right upper limb in supine position. Epidural analgesia was provided with a 10 ml bolus of 0.0625% bupivacaine and 2 mcg per ml of fentanyl in divided doses to achieve a level of T10. This was followed by maintenance infusion of 0.0625% bupivacaine and fentanyl of same concentration at 6 to 8 ml/hour.
